After the intervention of IL-38, SIRT1 was elevated in the CLL group (P<0.05 vs CIA), and HIF-1α, TLR4 and NF-κB p65 were decreased (P<0.05 vs CIA), which was affected by the IL-38 dose. The gene discussed is SIRT1; the disease is B-cell chronic lymphocytic leukemia.